CA2500217C - Formes cristallines de l'azithromycine - Google Patents

Formes cristallines de l'azithromycine Download PDF

Info

Publication number
CA2500217C
CA2500217C CA002500217A CA2500217A CA2500217C CA 2500217 C CA2500217 C CA 2500217C CA 002500217 A CA002500217 A CA 002500217A CA 2500217 A CA2500217 A CA 2500217A CA 2500217 C CA2500217 C CA 2500217C
Authority
CA
Canada
Prior art keywords
azithromycin
crystalline form
ppm
weight
peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002500217A
Other languages
English (en)
Other versions
CA2500217A1 (fr
Inventor
Zheng Jane Li
Andrew Vincent Trask
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Priority claimed from CA002391659A external-priority patent/CA2391659C/fr
Publication of CA2500217A1 publication Critical patent/CA2500217A1/fr
Application granted granted Critical
Publication of CA2500217C publication Critical patent/CA2500217C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002500217A 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine Expired - Fee Related CA2500217C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29256501P 2001-05-22 2001-05-22
US60/292,565 2001-05-22
US29774101P 2001-06-12 2001-06-12
US60/297,741 2001-06-12
US34304101P 2001-12-21 2001-12-21
US60/343,041 2001-12-21
CA002391659A CA2391659C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002391659A Division CA2391659C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine

Publications (2)

Publication Number Publication Date
CA2500217A1 CA2500217A1 (fr) 2002-11-22
CA2500217C true CA2500217C (fr) 2005-11-29

Family

ID=34577710

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002536914A Expired - Fee Related CA2536914C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine
CA002500217A Expired - Fee Related CA2500217C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine
CA002536501A Expired - Fee Related CA2536501C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002536914A Expired - Fee Related CA2536914C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002536501A Expired - Fee Related CA2536501C (fr) 2001-05-22 2002-05-01 Formes cristallines de l'azithromycine

Country Status (1)

Country Link
CA (3) CA2536914C (fr)

Also Published As

Publication number Publication date
CA2536501A1 (fr) 2002-11-22
CA2500217A1 (fr) 2002-11-22
CA2536501C (fr) 2006-09-26
CA2536914C (fr) 2008-01-15
CA2536914A1 (fr) 2002-11-22

Similar Documents

Publication Publication Date Title
US7053192B2 (en) Crystal forms of azithromycin
AU2002256846A1 (en) Crystal Forms of Azithromycin
CA2292359C (fr) Nouveaux azalides et procede de fabrication
US20020052328A1 (en) Macrolide antibiotics
ZA200308341B (en) Crystal Forms of Azithromycin.
CA2500217C (fr) Formes cristallines de l'azithromycine
EP1671979B1 (fr) Nouvelle forme cristalline de l'azithromycine
US6258785B1 (en) Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130501